Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B

Background: In the GLOBE trial, telbivudine demonstrated superior efficacy to lamivudine at 2 years in patients with chronic hepatitis B (CHB). Aims: To investigate the long-term efficacy and safety of telbivudine in the telbivudine-treated cohort from the GLOBE trial. Methods: Virological and bioch...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gane E., Wang Y., Liaw Y., Hou J., Thongsawat S., Wan M., Moon Y., Jia J., Chao Y., Niu J., Leung N., Samuel D., Hsu C., Bao W., Lopez P., Avila C.
Format:	Journal
Published:	2017
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79953315167&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43070
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B
by: Edward J. Gane, et al.
Published: (2018)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
by: Y. Wang, et al.
Published: (2018)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
by: Wang Y., et al.
Published: (2014)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
by: Y. Wang, et al.
Published: (2018)

Telbivudine versus lamivudine in patients with chronic hepatitis B
by: Ching Lung Lai, et al.
Published: (2018)

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
by: Zeuzem, S., et al.
Published: (2016)

Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial
by: Chan, H.L.Y., et al.
Published: (2016)

Telbivudine: A hepatitis B-specific antiviral
by: Lim, S.G.
Published: (2011)

Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy
by: Marcellin Patrick, et al.
Published: (2016)

Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: Pharmacodynamic implications
by: Zhou, X.-J., et al.
Published: (2016)

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: Results from the 2-year roadmap strategy
by: Teerha Piratvisuth, et al.
Published: (2018)

Ragaman Genetik Gen Polimerase Virus Hepatitis B Pada Pasien Hepatitis B Kronik dengan Pengobatan Telbivudine
by: Mastutik, Gondo, et al.
Published: (2015)

Evaluation of one-year lamivudine and telbivudine therapy on chronic hepatitis b patients: Based on biochemical, virological and fibrosis status in dr. soetomo general hospital
by: Ummi Maimunah, et al.
Published: (2019)

Evaluation of one year lamivudine and telbivudine therapy on chronic hepatitis b patient: Based on biochemical, virological and fibrosis status in dr. soetomo general hospital
by: Ummi Maimunah, et al.
Published: (2019)

Analisis Gen P Virus Hepatitis B (VHB) pada Serum Penderita Hepatitis B Kronik yang mendapat pengobatan Telbivudine dikaitkan dengan jumlah muatan virus sebelum pengobatan
by: Mastutik, Gondo, et al.
Published: (2010)

Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
by: Guan, R., et al.
Published: (2014)

Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
by: Guan, R., et al.
Published: (2016)

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study
by: Yun Fan Liaw, et al.
Published: (2018)

EVALUASI PEMBERIAN TERAPI LAMIVUDIN DAN TELBIVUDIN PADA PASIEN HEPATITIS B KRONIS DI RSUD DR. SOETOMO SURABAYA PADA PERIODE TERAPI 2014 – 2015
by: Erik Geraldus Edison, NIM011511133143
Published: (2018)

Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection
by: Soon, D.K.W., et al.
Published: (2014)

Prolonged Ambulatory Oesophageal pH and Pressure Recording in Healthy Adults in Singapore
by: Ho, K.Y., et al.
Published: (2014)

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection
by: Colvin,R.A., et al.
Published: (2015)

Co-encapsulation of bFGF-loaded microspheres and hepatocytes in microbeads for prolonging hepatic pre-transplantation
by: Saimok W.
Published: (2023)

Effects of massage therapy on trapezius muscle viscoelastic parameters following prolonged sitting
by: Liaw, Ying Hong
Published: (2017)

The significance of prolonged and saddleback fever in hospitalised adult dengue
by: Ng D.H.L., et al.
Published: (2019)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
by: Lau G.K.K., et al.
Published: (2014)

Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
by: Y. F. Liaw, et al.
Published: (2018)

Derivation of human feeders for prolonged support of human embryonic stem cells.
by: Fong, C.Y., et al.
Published: (2016)

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
by: Chang, T.-T., et al.
Published: (2016)

Solar Power Can Substantially Prolong Maximum Achievable Airtime of Quadcopter Drones
by: Lin, C.-F., et al.
Published: (2021)

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
by: Marcellin, P., et al.
Published: (2016)

Efficacy and safety of prolonged versus intermittent infusion of beta-lactam antibiotics as empirical therapy in patients with sepsis
by: S. Hemvimon, et al.
Published: (2020)

Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B
by: You, H, et al.
Published: (2020)

Metabolic adjustments in the common carp during prolonged hypoxia
by: Zhou, B.S., et al.
Published: (2014)

Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand
by: Kuang S.-Y., et al.
Published: (2014)

Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy
by: Kumthip K., et al.
Published: (2014)

Reduction of HBV replication prolongs the early immunological response to IFNα therapy
by: Tan, A.T., et al.
Published: (2016)

Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen
by: Wang, Y.M., et al.
Published: (2014)

The economics of treating chronic hepatitis B in Asia
by: Dan, Y.Y., et al.
Published: (2011)

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients
by: Patel K., et al.
Published: (2017)